These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

182 related articles for article (PubMed ID: 15776956)

  • 1. Exploring the future of non-small cell lung cancer treatment.
    Ramalingam S
    Manag Care; 2005 Feb; 14(2 Suppl):9-13; discussion 13-4. PubMed ID: 15776956
    [No Abstract]   [Full Text] [Related]  

  • 2. Modern treatment of lung cancer: case 1. Amplification and mutation of the epidermal growth factor receptor in metastatic lung cancer with remission from gefitinib.
    Schwab R; Pinter F; Moldavy J; Papay J; Strausz J; Kopper L; Keri G; Pap A; Petak I; Oreskovich K; Mangel L
    J Clin Oncol; 2005 Oct; 23(30):7736-8. PubMed ID: 16234532
    [No Abstract]   [Full Text] [Related]  

  • 3. Developing targeted therapies for lung cancer.
    Gandara DR
    Clin Adv Hematol Oncol; 2003 Nov; 1(11):648-9, 690. PubMed ID: 16258461
    [No Abstract]   [Full Text] [Related]  

  • 4. Perspectives in Lung Cancer--Third Asian-pacific Conference. 11-12 September 2009, Bangkok, Thailand.
    Lopes Gde L
    IDrugs; 2009 Nov; 12(11):689-91. PubMed ID: 19844853
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Targeted therapies and non-small-cell lung cancer: work in progress?
    Gridelli C
    Curr Opin Oncol; 2006 Mar; 18(2):132-4. PubMed ID: 16462181
    [No Abstract]   [Full Text] [Related]  

  • 6. Antiangiogenic therapy in nonsmall cell lung cancer.
    Gutierrez M; Giaccone G
    Curr Opin Oncol; 2008 Mar; 20(2):176-82. PubMed ID: 18300767
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Integrating new targeted agents into the treatment of non-small-cell lung cancer.
    Thatcher N
    Lung Cancer; 2006 Dec; 54 Suppl 2():S25-31. PubMed ID: 17056150
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Epidermal growth factor receptor mutations in lung cancer.
    Sharma SV; Bell DW; Settleman J; Haber DA
    Nat Rev Cancer; 2007 Mar; 7(3):169-81. PubMed ID: 17318210
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Genetic polymorphisms of the epidermal growth factor and related receptor in non-small cell lung cancer--a review of the literature.
    Araújo A; Ribeiro R; Azevedo I; Coelho A; Soares M; Sousa B; Pinto D; Lopes C; Medeiros R; Scagliotti GV
    Oncologist; 2007 Feb; 12(2):201-10. PubMed ID: 17296816
    [TBL] [Abstract][Full Text] [Related]  

  • 10. New biological agents in the treatment of advanced non-small cell lung cancer.
    Morrow PK; Kim ES
    Semin Respir Crit Care Med; 2005 Jun; 26(3):323-32. PubMed ID: 16052434
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Off-label uses of bevacizumab: breast and lung cancer indications.
    Technol Eval Cent Assess Program Exec Summ; 2006 Oct; 21(8):1-4. PubMed ID: 17061398
    [No Abstract]   [Full Text] [Related]  

  • 12. Functional analysis of epidermal growth factor receptor (EGFR) mutations and potential implications for EGFR targeted therapy.
    Kancha RK; von Bubnoff N; Peschel C; Duyster J
    Clin Cancer Res; 2009 Jan; 15(2):460-7. PubMed ID: 19147750
    [TBL] [Abstract][Full Text] [Related]  

  • 13. EGFR antagonists in cancer treatment.
    Ciardiello F; Tortora G
    N Engl J Med; 2008 Mar; 358(11):1160-74. PubMed ID: 18337605
    [No Abstract]   [Full Text] [Related]  

  • 14. The emerging role of vascular endothelial growth factor receptor tyrosine kinase inhibitors.
    Langer CJ; Natale RB
    Semin Oncol; 2005 Dec; 32(6 Suppl 10):S23-9. PubMed ID: 16459176
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The biology of non-small-cell lung cancer: identifying new targets for rational therapy.
    Rosell R; Felip E; Garcia-Campelo R; Balaña C
    Lung Cancer; 2004 Nov; 46(2):135-48. PubMed ID: 15474661
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Responses to targeted therapies: lung cancer].
    Brambilla E
    Ann Pathol; 2009 Nov; 29 Spec No 1():S77-80. PubMed ID: 19887261
    [No Abstract]   [Full Text] [Related]  

  • 17. Lung cancer.
    Hansen HH; Rørth M
    Cancer Chemother Biol Response Modif; 1991; 12():443-59. PubMed ID: 1657089
    [No Abstract]   [Full Text] [Related]  

  • 18. [Targeted therapies for lung cancer].
    Tamura K
    Rinsho Ketsueki; 2008 Aug; 49(8):616-21. PubMed ID: 18800610
    [No Abstract]   [Full Text] [Related]  

  • 19. New targets for the treatment of advanced non-small cell lung cancer.
    Massarelli E; Onn A; Zinner R; Khuri FR; Kim ES; Herbst RS
    Cancer Chemother Biol Response Modif; 2002; 20():717-61. PubMed ID: 12703232
    [No Abstract]   [Full Text] [Related]  

  • 20. [Bevacizumab in the treatment of non-small cell lung cancer].
    Knuuttila A; Rouhos A; Karjalainen EM; Riska H; Pietiläinen M; Paunu N; Salomaa ER
    Duodecim; 2009; 125(4):361-8. PubMed ID: 19358416
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.